Global Prostate Cancer Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 16040 million in 2024 and is forecast to a readjusted size of USD 26670 million by 2031 with a CAGR of 7.6% during review period.
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.
This report is a detailed and comprehensive analysis for global Prostate Cancer Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prostate Cancer Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Prostate Cancer Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Prostate Cancer Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Prostate Cancer Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostate Cancer Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostate Cancer Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Prostate Cancer Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prostate Cancer Diagnostics, with revenue, gross margin, and global market share of Prostate Cancer Diagnostics from 2020 to 2025.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Prostate Cancer Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate Cancer Diagnostics.
Chapter 13, to describe Prostate Cancer Diagnostics research findings and conclusion.
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.
This report is a detailed and comprehensive analysis for global Prostate Cancer Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prostate Cancer Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Prostate Cancer Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Prostate Cancer Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Prostate Cancer Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostate Cancer Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostate Cancer Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Prostate Cancer Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tumor Biomarker Tests
- Imaging
- Biopsy
- Other
- Age Below 55
- Age 55-75
- Age Above 75
- OPKO
- Genomic Health
- Abbott
- Beckman Coulter
- Siemens Healthcare
- bioMeriux
- Roche
- MDx Health
- DiaSorin
- Myriad Genetics
- Ambry Genetics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prostate Cancer Diagnostics, with revenue, gross margin, and global market share of Prostate Cancer Diagnostics from 2020 to 2025.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Prostate Cancer Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate Cancer Diagnostics.
Chapter 13, to describe Prostate Cancer Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prostate Cancer Diagnostics by Type
1.3.1 Overview: Global Prostate Cancer Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Prostate Cancer Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 Tumor Biomarker Tests
1.3.4 Imaging
1.3.5 Biopsy
1.3.6 Other
1.4 Global Prostate Cancer Diagnostics Market by Application
1.4.1 Overview: Global Prostate Cancer Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Age Below 55
1.4.3 Age 55-75
1.4.4 Age Above 75
1.5 Global Prostate Cancer Diagnostics Market Size & Forecast
1.6 Global Prostate Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Prostate Cancer Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Prostate Cancer Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 OPKO
2.1.1 OPKO Details
2.1.2 OPKO Major Business
2.1.3 OPKO Prostate Cancer Diagnostics Product and Solutions
2.1.4 OPKO Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 OPKO Recent Developments and Future Plans
2.2 Genomic Health
2.2.1 Genomic Health Details
2.2.2 Genomic Health Major Business
2.2.3 Genomic Health Prostate Cancer Diagnostics Product and Solutions
2.2.4 Genomic Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Genomic Health Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Prostate Cancer Diagnostics Product and Solutions
2.3.4 Abbott Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Prostate Cancer Diagnostics Product and Solutions
2.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare Prostate Cancer Diagnostics Product and Solutions
2.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Siemens Healthcare Recent Developments and Future Plans
2.6 bioMeriux
2.6.1 bioMeriux Details
2.6.2 bioMeriux Major Business
2.6.3 bioMeriux Prostate Cancer Diagnostics Product and Solutions
2.6.4 bioMeriux Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 bioMeriux Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Prostate Cancer Diagnostics Product and Solutions
2.7.4 Roche Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Roche Recent Developments and Future Plans
2.8 MDx Health
2.8.1 MDx Health Details
2.8.2 MDx Health Major Business
2.8.3 MDx Health Prostate Cancer Diagnostics Product and Solutions
2.8.4 MDx Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MDx Health Recent Developments and Future Plans
2.9 DiaSorin
2.9.1 DiaSorin Details
2.9.2 DiaSorin Major Business
2.9.3 DiaSorin Prostate Cancer Diagnostics Product and Solutions
2.9.4 DiaSorin Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 DiaSorin Recent Developments and Future Plans
2.10 Myriad Genetics
2.10.1 Myriad Genetics Details
2.10.2 Myriad Genetics Major Business
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Product and Solutions
2.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Myriad Genetics Recent Developments and Future Plans
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Product and Solutions
2.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Ambry Genetics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Prostate Cancer Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Prostate Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Prostate Cancer Diagnostics Players Market Share in 2024
3.2.3 Top 6 Prostate Cancer Diagnostics Players Market Share in 2024
3.3 Prostate Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Prostate Cancer Diagnostics Market: Region Footprint
3.3.2 Prostate Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Prostate Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Prostate Cancer Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Prostate Cancer Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Prostate Cancer Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Prostate Cancer Diagnostics Market Size by Application (2020-2031)
6.3 North America Prostate Cancer Diagnostics Market Size by Country
6.3.1 North America Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Prostate Cancer Diagnostics Market Size by Country
7.3.1 Europe Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Prostate Cancer Diagnostics Market Size by Country
9.3.1 South America Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Prostate Cancer Diagnostics Market Drivers
11.2 Prostate Cancer Diagnostics Market Restraints
11.3 Prostate Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Prostate Cancer Diagnostics Industry Chain
12.2 Prostate Cancer Diagnostics Upstream Analysis
12.3 Prostate Cancer Diagnostics Midstream Analysis
12.4 Prostate Cancer Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prostate Cancer Diagnostics by Type
1.3.1 Overview: Global Prostate Cancer Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Prostate Cancer Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 Tumor Biomarker Tests
1.3.4 Imaging
1.3.5 Biopsy
1.3.6 Other
1.4 Global Prostate Cancer Diagnostics Market by Application
1.4.1 Overview: Global Prostate Cancer Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Age Below 55
1.4.3 Age 55-75
1.4.4 Age Above 75
1.5 Global Prostate Cancer Diagnostics Market Size & Forecast
1.6 Global Prostate Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Prostate Cancer Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Prostate Cancer Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Prostate Cancer Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 OPKO
2.1.1 OPKO Details
2.1.2 OPKO Major Business
2.1.3 OPKO Prostate Cancer Diagnostics Product and Solutions
2.1.4 OPKO Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 OPKO Recent Developments and Future Plans
2.2 Genomic Health
2.2.1 Genomic Health Details
2.2.2 Genomic Health Major Business
2.2.3 Genomic Health Prostate Cancer Diagnostics Product and Solutions
2.2.4 Genomic Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Genomic Health Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Prostate Cancer Diagnostics Product and Solutions
2.3.4 Abbott Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Prostate Cancer Diagnostics Product and Solutions
2.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare Prostate Cancer Diagnostics Product and Solutions
2.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Siemens Healthcare Recent Developments and Future Plans
2.6 bioMeriux
2.6.1 bioMeriux Details
2.6.2 bioMeriux Major Business
2.6.3 bioMeriux Prostate Cancer Diagnostics Product and Solutions
2.6.4 bioMeriux Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 bioMeriux Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Prostate Cancer Diagnostics Product and Solutions
2.7.4 Roche Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Roche Recent Developments and Future Plans
2.8 MDx Health
2.8.1 MDx Health Details
2.8.2 MDx Health Major Business
2.8.3 MDx Health Prostate Cancer Diagnostics Product and Solutions
2.8.4 MDx Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MDx Health Recent Developments and Future Plans
2.9 DiaSorin
2.9.1 DiaSorin Details
2.9.2 DiaSorin Major Business
2.9.3 DiaSorin Prostate Cancer Diagnostics Product and Solutions
2.9.4 DiaSorin Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 DiaSorin Recent Developments and Future Plans
2.10 Myriad Genetics
2.10.1 Myriad Genetics Details
2.10.2 Myriad Genetics Major Business
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Product and Solutions
2.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Myriad Genetics Recent Developments and Future Plans
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Product and Solutions
2.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Ambry Genetics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Prostate Cancer Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Prostate Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Prostate Cancer Diagnostics Players Market Share in 2024
3.2.3 Top 6 Prostate Cancer Diagnostics Players Market Share in 2024
3.3 Prostate Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Prostate Cancer Diagnostics Market: Region Footprint
3.3.2 Prostate Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Prostate Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Prostate Cancer Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Prostate Cancer Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Prostate Cancer Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Prostate Cancer Diagnostics Market Size by Application (2020-2031)
6.3 North America Prostate Cancer Diagnostics Market Size by Country
6.3.1 North America Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Prostate Cancer Diagnostics Market Size by Country
7.3.1 Europe Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Prostate Cancer Diagnostics Market Size by Country
9.3.1 South America Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Prostate Cancer Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Prostate Cancer Diagnostics Market Drivers
11.2 Prostate Cancer Diagnostics Market Restraints
11.3 Prostate Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Prostate Cancer Diagnostics Industry Chain
12.2 Prostate Cancer Diagnostics Upstream Analysis
12.3 Prostate Cancer Diagnostics Midstream Analysis
12.4 Prostate Cancer Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Prostate Cancer Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Prostate Cancer Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Prostate Cancer Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Prostate Cancer Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. OPKO Company Information, Head Office, and Major Competitors
Table 6. OPKO Major Business
Table 7. OPKO Prostate Cancer Diagnostics Product and Solutions
Table 8. OPKO Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. OPKO Recent Developments and Future Plans
Table 10. Genomic Health Company Information, Head Office, and Major Competitors
Table 11. Genomic Health Major Business
Table 12. Genomic Health Prostate Cancer Diagnostics Product and Solutions
Table 13. Genomic Health Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Genomic Health Recent Developments and Future Plans
Table 15. Abbott Company Information, Head Office, and Major Competitors
Table 16. Abbott Major Business
Table 17. Abbott Prostate Cancer Diagnostics Product and Solutions
Table 18. Abbott Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 20. Beckman Coulter Major Business
Table 21. Beckman Coulter Prostate Cancer Diagnostics Product and Solutions
Table 22. Beckman Coulter Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Beckman Coulter Recent Developments and Future Plans
Table 24. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 25. Siemens Healthcare Major Business
Table 26. Siemens Healthcare Prostate Cancer Diagnostics Product and Solutions
Table 27. Siemens Healthcare Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Siemens Healthcare Recent Developments and Future Plans
Table 29. bioMeriux Company Information, Head Office, and Major Competitors
Table 30. bioMeriux Major Business
Table 31. bioMeriux Prostate Cancer Diagnostics Product and Solutions
Table 32. bioMeriux Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. bioMeriux Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Prostate Cancer Diagnostics Product and Solutions
Table 37. Roche Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Roche Recent Developments and Future Plans
Table 39. MDx Health Company Information, Head Office, and Major Competitors
Table 40. MDx Health Major Business
Table 41. MDx Health Prostate Cancer Diagnostics Product and Solutions
Table 42. MDx Health Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. MDx Health Recent Developments and Future Plans
Table 44. DiaSorin Company Information, Head Office, and Major Competitors
Table 45. DiaSorin Major Business
Table 46. DiaSorin Prostate Cancer Diagnostics Product and Solutions
Table 47. DiaSorin Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. DiaSorin Recent Developments and Future Plans
Table 49. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 50. Myriad Genetics Major Business
Table 51. Myriad Genetics Prostate Cancer Diagnostics Product and Solutions
Table 52. Myriad Genetics Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Myriad Genetics Recent Developments and Future Plans
Table 54. Ambry Genetics Company Information, Head Office, and Major Competitors
Table 55. Ambry Genetics Major Business
Table 56. Ambry Genetics Prostate Cancer Diagnostics Product and Solutions
Table 57. Ambry Genetics Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Ambry Genetics Recent Developments and Future Plans
Table 59. Global Prostate Cancer Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 60. Global Prostate Cancer Diagnostics Revenue Share by Players (2020-2025)
Table 61. Breakdown of Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Prostate Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 63. Head Office of Key Prostate Cancer Diagnostics Players
Table 64. Prostate Cancer Diagnostics Market: Company Product Type Footprint
Table 65. Prostate Cancer Diagnostics Market: Company Product Application Footprint
Table 66. Prostate Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 67. Prostate Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Prostate Cancer Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 69. Global Prostate Cancer Diagnostics Consumption Value Share by Type (2020-2025)
Table 70. Global Prostate Cancer Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 71. Global Prostate Cancer Diagnostics Consumption Value by Application (2020-2025)
Table 72. Global Prostate Cancer Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 73. North America Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 74. North America Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 75. North America Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 80. Europe Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 81. Europe Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 86. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 87. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 92. South America Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 93. South America Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 98. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 99. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of Prostate Cancer Diagnostics Upstream (Raw Materials)
Table 104. Global Prostate Cancer Diagnostics Typical Customers
Table 1. Global Prostate Cancer Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Prostate Cancer Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Prostate Cancer Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Prostate Cancer Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. OPKO Company Information, Head Office, and Major Competitors
Table 6. OPKO Major Business
Table 7. OPKO Prostate Cancer Diagnostics Product and Solutions
Table 8. OPKO Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. OPKO Recent Developments and Future Plans
Table 10. Genomic Health Company Information, Head Office, and Major Competitors
Table 11. Genomic Health Major Business
Table 12. Genomic Health Prostate Cancer Diagnostics Product and Solutions
Table 13. Genomic Health Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Genomic Health Recent Developments and Future Plans
Table 15. Abbott Company Information, Head Office, and Major Competitors
Table 16. Abbott Major Business
Table 17. Abbott Prostate Cancer Diagnostics Product and Solutions
Table 18. Abbott Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 20. Beckman Coulter Major Business
Table 21. Beckman Coulter Prostate Cancer Diagnostics Product and Solutions
Table 22. Beckman Coulter Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Beckman Coulter Recent Developments and Future Plans
Table 24. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 25. Siemens Healthcare Major Business
Table 26. Siemens Healthcare Prostate Cancer Diagnostics Product and Solutions
Table 27. Siemens Healthcare Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Siemens Healthcare Recent Developments and Future Plans
Table 29. bioMeriux Company Information, Head Office, and Major Competitors
Table 30. bioMeriux Major Business
Table 31. bioMeriux Prostate Cancer Diagnostics Product and Solutions
Table 32. bioMeriux Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. bioMeriux Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Prostate Cancer Diagnostics Product and Solutions
Table 37. Roche Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Roche Recent Developments and Future Plans
Table 39. MDx Health Company Information, Head Office, and Major Competitors
Table 40. MDx Health Major Business
Table 41. MDx Health Prostate Cancer Diagnostics Product and Solutions
Table 42. MDx Health Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. MDx Health Recent Developments and Future Plans
Table 44. DiaSorin Company Information, Head Office, and Major Competitors
Table 45. DiaSorin Major Business
Table 46. DiaSorin Prostate Cancer Diagnostics Product and Solutions
Table 47. DiaSorin Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. DiaSorin Recent Developments and Future Plans
Table 49. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 50. Myriad Genetics Major Business
Table 51. Myriad Genetics Prostate Cancer Diagnostics Product and Solutions
Table 52. Myriad Genetics Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Myriad Genetics Recent Developments and Future Plans
Table 54. Ambry Genetics Company Information, Head Office, and Major Competitors
Table 55. Ambry Genetics Major Business
Table 56. Ambry Genetics Prostate Cancer Diagnostics Product and Solutions
Table 57. Ambry Genetics Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Ambry Genetics Recent Developments and Future Plans
Table 59. Global Prostate Cancer Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 60. Global Prostate Cancer Diagnostics Revenue Share by Players (2020-2025)
Table 61. Breakdown of Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Prostate Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 63. Head Office of Key Prostate Cancer Diagnostics Players
Table 64. Prostate Cancer Diagnostics Market: Company Product Type Footprint
Table 65. Prostate Cancer Diagnostics Market: Company Product Application Footprint
Table 66. Prostate Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 67. Prostate Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Prostate Cancer Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 69. Global Prostate Cancer Diagnostics Consumption Value Share by Type (2020-2025)
Table 70. Global Prostate Cancer Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 71. Global Prostate Cancer Diagnostics Consumption Value by Application (2020-2025)
Table 72. Global Prostate Cancer Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 73. North America Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 74. North America Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 75. North America Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 80. Europe Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 81. Europe Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 86. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 87. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific Prostate Cancer Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 92. South America Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 93. South America Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 98. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 99. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa Prostate Cancer Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of Prostate Cancer Diagnostics Upstream (Raw Materials)
Table 104. Global Prostate Cancer Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Prostate Cancer Diagnostics Picture
Figure 2. Global Prostate Cancer Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Prostate Cancer Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. Tumor Biomarker Tests
Figure 5. Imaging
Figure 6. Biopsy
Figure 7. Other
Figure 8. Global Prostate Cancer Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Prostate Cancer Diagnostics Consumption Value Market Share by Application in 2024
Figure 10. Age Below 55 Picture
Figure 11. Age 55-75 Picture
Figure 12. Age Above 75 Picture
Figure 13. Global Prostate Cancer Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Prostate Cancer Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Prostate Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Prostate Cancer Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Prostate Cancer Diagnostics Consumption Value Market Share by Region in 2024
Figure 18. North America Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Prostate Cancer Diagnostics Revenue Share by Players in 2024
Figure 25. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Prostate Cancer Diagnostics by Player Revenue in 2024
Figure 27. Top 3 Prostate Cancer Diagnostics Players Market Share in 2024
Figure 28. Top 6 Prostate Cancer Diagnostics Players Market Share in 2024
Figure 29. Global Prostate Cancer Diagnostics Consumption Value Share by Type (2020-2025)
Figure 30. Global Prostate Cancer Diagnostics Market Share Forecast by Type (2026-2031)
Figure 31. Global Prostate Cancer Diagnostics Consumption Value Share by Application (2020-2025)
Figure 32. Global Prostate Cancer Diagnostics Market Share Forecast by Application (2026-2031)
Figure 33. North America Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. France Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Prostate Cancer Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 50. China Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. India Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 67. Prostate Cancer Diagnostics Market Drivers
Figure 68. Prostate Cancer Diagnostics Market Restraints
Figure 69. Prostate Cancer Diagnostics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Prostate Cancer Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Prostate Cancer Diagnostics Picture
Figure 2. Global Prostate Cancer Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Prostate Cancer Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. Tumor Biomarker Tests
Figure 5. Imaging
Figure 6. Biopsy
Figure 7. Other
Figure 8. Global Prostate Cancer Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Prostate Cancer Diagnostics Consumption Value Market Share by Application in 2024
Figure 10. Age Below 55 Picture
Figure 11. Age 55-75 Picture
Figure 12. Age Above 75 Picture
Figure 13. Global Prostate Cancer Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Prostate Cancer Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Prostate Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Prostate Cancer Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Prostate Cancer Diagnostics Consumption Value Market Share by Region in 2024
Figure 18. North America Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Prostate Cancer Diagnostics Revenue Share by Players in 2024
Figure 25. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Prostate Cancer Diagnostics by Player Revenue in 2024
Figure 27. Top 3 Prostate Cancer Diagnostics Players Market Share in 2024
Figure 28. Top 6 Prostate Cancer Diagnostics Players Market Share in 2024
Figure 29. Global Prostate Cancer Diagnostics Consumption Value Share by Type (2020-2025)
Figure 30. Global Prostate Cancer Diagnostics Market Share Forecast by Type (2026-2031)
Figure 31. Global Prostate Cancer Diagnostics Consumption Value Share by Application (2020-2025)
Figure 32. Global Prostate Cancer Diagnostics Market Share Forecast by Application (2026-2031)
Figure 33. North America Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. France Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Prostate Cancer Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 50. China Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. India Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Prostate Cancer Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Prostate Cancer Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Prostate Cancer Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Prostate Cancer Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 67. Prostate Cancer Diagnostics Market Drivers
Figure 68. Prostate Cancer Diagnostics Market Restraints
Figure 69. Prostate Cancer Diagnostics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Prostate Cancer Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
